BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 17213724)

  • 1. Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement.
    Mégevand P; Chizzolini C; Chofflon M; Roux-Lombard P; Lalive PH; Picard F
    Eur Neurol; 2007; 57(3):166-71. PubMed ID: 17213724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominance of IgG1 subclass of anti-Ro/SSA, but not anti-La/SSB antibodies in primary Sjögren's syndrome.
    Maran R; Dueymes M; Pennec YL; Casburn-Budd R; Shoenfeld Y; Youinou P
    J Autoimmun; 1993 Jun; 6(3):379-87. PubMed ID: 8397718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
    Miyawaki S
    Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult heart block is associated with disease activity in primary Sjögren's syndrome.
    Lodde BM; Sankar V; Kok MR; Leakan RA; Tak PP; Pillemer SR
    Scand J Rheumatol; 2005; 34(5):383-6. PubMed ID: 16234186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
    Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
    Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X
    Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome.
    Katano K; Kawano M; Koni I; Sugai S; Muro Y
    J Rheumatol; 2001 Oct; 28(10):2238-44. PubMed ID: 11669163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphous exudates and atypical mononuclear cells in the cerebrospinal fluid of patients with Sjögren's syndrome.
    de la Monte S; Gupta PK; Hutchins GM
    Acta Cytol; 1985; 29(4):634-7. PubMed ID: 3861056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of primary Sjogren's syndrome].
    Gran JT; Myklebust G
    Tidsskr Nor Laegeforen; 2001 Feb; 121(5):563-6. PubMed ID: 11301610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sjögren's Syndrome: a retrospective analysis of 65 patients in the Netherlands.
    ter Borg EJ; Risselada AP; Kelder JC
    Semin Arthritis Rheum; 2011 Jun; 40(6):547-51. PubMed ID: 20864144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.
    Toker E; Yavuz S; Direskeneli H
    Br J Ophthalmol; 2004 Mar; 88(3):384-7. PubMed ID: 14977774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA rheumatoid factor in primary Sjogren's syndrome.
    Peen E; Mellbye OJ; Haga HJ
    Scand J Rheumatol; 2009; 38(1):46-9. PubMed ID: 18942022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
    Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome.
    Ruiz-Tíscar JL; López-Longo FJ; Sánchez-Ramón S; Santamaría B; Urrea R; Carreño L; Estecha A; Vigil D; Fernández-Cruz E; Rodríguez-Mahou M
    Ann N Y Acad Sci; 2005 Jun; 1050():210-6. PubMed ID: 16014536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The application of combined detection of autoantibodies in primary Sjögren's syndrome].
    He J; Fang W; Li ZG
    Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):366-8. PubMed ID: 18953942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the anti-Ro/SSA autoantibody profile between patients with primary and secondary Sjögren's syndrome.
    Gál I; Lakos G; Zeher M
    Autoimmunity; 2000 Sep; 32(2):89-92. PubMed ID: 11078154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
    Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K
    J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Ro (SSA) and anti-La (SSB) antibodies in lupus erythematosus and in Sjögren's syndrome.
    Lee LA
    Arch Dermatol; 1988 Jan; 124(1):61-2. PubMed ID: 3257370
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.
    Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M
    J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of anti-Fc gamma receptor autoantibodies is related to the clinical presentation of primary Sjögren's syndrome.
    Lamour A; Le Corre R; Pennec YL; Youinou P
    J Rheumatol; 1995 Dec; 22(12):2241-5. PubMed ID: 8835556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.